Target intelligence / Profile preview

RNA, U6 small nuclear 641, pseudogene (RNU6-641P)

Target
RNU6-641P
Molecular classification
Other (Pseudogene; Small nuclear RNA-derived)
01

Overview

RNU6-641P is a *processed pseudogene*—a DNA segment that closely resembles the U6 small nuclear RNA gene, originally functional in RNA splicing as part of the spliceosome, but which now lacks a functional promoter or regulatory regions[6][4]. As a pseudogene, it is not transcribed or translated and does not encode functional protein or RNA. U6 snRNA itself is essential for pre-mRNA splicing in the nucleus, but pseudogenes such as RNU6-641P accumulate in the genome, typically as a result of retrotransposition[6][1]. These sequences are common backups found in vertebrate genomes, reflecting evolutionary history rather than active biological function[5][6][4]. There is no evidence that RNU6-641P or similar U6 pseudogenes are involved in disease, can serve as therapeutic targets, interact with drugs, act as biomarkers, or pose safety concerns. The listing is considered incorrect in the context of drug, therapeutic, or receptor target databases, as pseudogenes like RNU6-641P are not considered actionable molecular targets or functional biomolecules[6][4].

Other names
RNU6-641PRNA, U6 small nuclear 641, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 641, pseudogene (RNU6-641P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 641, pseudogene (RNU6-641P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call